Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia

Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

NCT00380575 ·Status: COMPLETED ·Phase: PHASE3

Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide

NCT02399358 ·Status: UNKNOWN

Low-dose Tolvaptan for Inpatient Hyponatraemia.

NCT06171100 ·Status: RECRUITING

Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

NCT00684164 ·Status: WITHDRAWN ·Phase: PHASE3

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

NCT01056848 ·Status: COMPLETED

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT04447911 ·Status: RECRUITING ·Phase: PHASE4

Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure

NCT04618601 ·Status: UNKNOWN ·Phase: PHASE4

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

NCT02545101 ·Status: COMPLETED

Saline Infusion Test in Hyponatremia

NCT06498856 ·Status: NOT_YET_RECRUITING

Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia

NCT03557957 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients

NCT03658850 ·Status: UNKNOWN ·Phase: PHASE2

Aquaresis Utility for Hyponatremic Acute Heart Failure Study

NCT02183792 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)

NCT00843986 ·Status: TERMINATED ·Phase: PHASE3

Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome

NCT05055856 ·Status: COMPLETED ·Phase: NA

Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure

NCT02352285 ·Status: TERMINATED ·Phase: PHASE4

Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.

NCT05408481 ·Status: UNKNOWN

The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects

NCT01414088 ·Status: COMPLETED ·Phase: NA

Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

NCT01687699 ·Status: COMPLETED ·Phase: PHASE4

Sodium Management in Acute and Chronic Heart Failure

NCT01156337 ·Status: COMPLETED

Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients

NCT01456533 ·Status: COMPLETED

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

NCT00728091 ·Status: TERMINATED ·Phase: PHASE3

Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease

NCT01623661 ·Status: COMPLETED ·Phase: NA

International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia

NCT00876876 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

NCT00435591 ·Status: COMPLETED ·Phase: PHASE4

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia

NCT00660959 ·Status: COMPLETED ·Phase: PHASE3